# US 2022/0031626 A1 · Kind of Chinese medicine and microcapsule preparation method suitable for nasopharyngeal carcinoma tumor inhibitor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031626 A1
- Document ID: US20220031626A1
- Status: Published application
- Kind: A1
- Application number: 17/450,836
- Filed: 2021-10-14
- Published: 2022-02-03
- Earliest claimed: 2021-10-14
- Assignees: Haowei Ti
- Inventors: Haowei Ti; Shiqi Mei; Donghai Mei
- Web page: https://patentgrep.com/patent/US20220031626A1

## CPC

- A61K 9/10: Dispersions; Emulsions
- A61K 9/5052: {Proteins, e.g. albumin}
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/5036: {Polysaccharides, e.g. gums, alginate; Cyclodextrin}
- A61K 9/5063: {Compounds of unknown constitution, e.g. material from plants or animals (oils, fats, waxes, shellac A61K9/5015)}
- A61K 9/5089: {Processes}
- A61K 36/288: Taraxacum (dandelion)
- A61K 36/346: Platycodon
- A61K 36/47: Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
- A61K 36/533: Leonurus (motherwort)
- A61K 36/539: Scutellaria (skullcap)
- A61K 36/54: Lauraceae (Laurel family), e.g. cinnamon or sassafras
- A61K 36/59: Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
- A61K 36/634: Forsythia
- A61K 36/64: Orobanchaceae (Broom-rape family)
- A61K 36/748: Oldenlandia or Hedyotis
- A61K 36/9066: Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
- A61P 35/00: Antineoplastic agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention relates to the technical field of traditional Chinese medicine, and discloses a method of traditional Chinese medicine and microcapsule preparation suitable for nasopharyngeal cancer tumor inhibitors. A traditional Chinese medicine suitable for nasopharyngeal cancer tumor inhibitors, including: Hedyotis Diffusa, Scutellaria Barbata, Arrowshaped Tinospora Root, Rehmanniae Radix Preparata, Radix Curcumae, Crotonis Fructus, Leonurus Artemisia, Ramulus Cinnamomi, Forsythiae Fructus, Taraxacum, Radix Platycodonis and White Vinegar. Among them, the raw materials for the weight ratio are as follows: 60 grams of Hedyotis Diffusa, 30 grams of Scutellaria Barbata, 9-12 grams of Arrowshaped Tinospora Root, 18 grams of Rehmanniae Radix Preparata, 19 grams of Radix Curcumae, 7.5 grams of Crotonis Fructus, 10 grams of Leonurus Artemisia, 7-10 grams of Ramulus Cinnamomi, 10 grams of Forsythiae Fructus, 15-30 grams of Taraxacum, 10 g of Radix Platycodonis, and 30 ml of White Vinegar.

## Claims

### Claim 1

A Chinese medicine suitable for nasopharyngeal cancer tumor inhibitors, which is characterized in that it comprises: Hedyotis Diffusa, Scutellaria Barbata, Arrowshaped Tinospora Root, Rehmanniae Radix Preparata, Radix Curcumae, Crotonis Fructus, Leonurus Artemisia, Ramulus Cinnamomi, Forsythiae Fructus, Taraxacum, Radix Platycodonis and White Vinegaris and White Vinegar. Among them, the raw materials for the weight ratio are as follows: 60 grams of Hedyotis Diffusa, 30 grams of Scutellaria Barbata, 9-12 grams of Arrowshaped Tinospora Root, 18 grams of Rehmanniae Radix Preparata, 19 grams of Radix Curcumae, 7.5 grams of Crotonis Fructus, 10 grams of Leonurus Artemisia, 7-10 grams of Ramulus Cinnamomi, 10 grams of Forsythiae Fructus, 15-30 grams of Taraxacum, 10 g of Radix Platycodonis , and 30 ml of White Vinegar.

### Claim 2

A preparation method of traditional Chinese medicine microcapsules suitable for nasopharyngeal cancer tumor inhibitors is characterized in that it comprises the following steps:
1) Milk protein is used as the main wall material, and Artemisia annua starch is used as the auxiliary wall material. The auxiliary wall material accounts for 0-90% of the wall material mass;
the microcapsule preparation uses radix platycodonis oil as the core material;
2) The wall material is crushed to above 90 mesh and mixed evenly. Then, under the condition of stirring, slowly add the core material, after stirring and mixing uniformly, the formed core material is evenly dispersed in the inhibitor under stirring. After the wall material is fully hydrated, it is homogenized by a homogenizer at 20-40 MPa for 2 to 4 times to obtain a stable emulsion and complete the microcapsule embedding process;
3) The emulsion uses high temperature heat treatment, aldehyde cross-linking and enzymatic exchange methods to solidify the wall material protein, so that the microcapsule wall is insoluble in water, and the core material is solid or semi-solid in water;
4) The curing liquid is spray-dried to become a free-flowing solid powder.

### Claim 3 (depends on 2)

The preparation method of traditional Chinese medicine microcapsules suitable for nasopharyngeal cancer tumor inhibitors according to claim 2, wherein the core material accounts for 55% of the mass of the microcapsules.
